Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
BiologicsGene Therapeutics & RNAi

PUBLISHER: Grand View Research | PRODUCT CODE: 1888752

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1888752

Nucleic Acid Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Gene Therapy, RNA-based Therapies), By Service, By End Use, By Application, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Nucleic Acid Therapeutics Contract Manufacturing Market Summary

The global nucleic acid therapeutics contract manufacturing market size was estimated at USD 9.85 billion in 2024 and is projected to reach USD 33.84 billion by 2033, growing at a CAGR of 15.14% from 2025 to 2033. The market is witnessing growth driven by growing biopharmaceutical outsourcing trends, rising demand for mRNA and gene therapies, and technological advancements in manufacturing.

Increasing regulatory support and government incentives are among the other factors driving market growth. In the global market, shifting trends towards outsourcing activities by biopharmaceutical companies to contract manufacturers are expected to drive market growth. This outsourcing activity reduces operational costs, accelerates time-to-market, and utilizes specialized expertise in nucleic acid production. According to an article published in July 2025, 82.6% of cell and gene therapy (CGT) companies outsource at least part of their biologics manufacturing, marking record-high levels of reliance on external contract manufacturing services.

In addition, outsourcing activities is also driven by the high complexity of mRNA, plasmid DNA, and oligonucleotide therapeutics, which require GMP-certified facilities, skilled personnel, and advanced technologies. Thus, contract manufacturers are witnessing an increasing requirement for integrated services, including process development, analytical testing, and commercial-scale manufacturing. In addition, outsourcing enables pharmaceutical firms to concentrate on research and development, ensuring that regulatory compliance and quality standards are met.

Global Nucleic Acid Therapeutics Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nucleic acid therapeutics contract manufacturing market report based on type, service, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Gene Therapy
    • Plasmid DNA (pDNA)
    • Viral Vectors
    • Non-viral Gene Delivery Systems
    • Others
  • RNA-based Therapies
    • Messenger RNA (mRNA)
    • Small Interfering RNA (siRNA)
    • Antisense Oligonucleotides (ASO)
    • Other
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Process Development and Optimization
  • GMP Manufacturing
  • Analytical and Quality Control Service
  • Fill-Finish Contract Manufacturing
  • Regulatory Support
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Rare Diseases
  • Genetic Disorders
  • Infectious Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Biopharmaceutical Companies
  • Medium Biopharmaceutical Companies
  • Small Biopharmaceutical Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman
Show more
Product Code: GVR-4-68040-809-4

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Service
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Nucleic Acid Therapeutics Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Demand for Cell and Gene Therapies
      • 3.2.1.2. Increased Outsourcing by Biopharma Companies
      • 3.2.1.3. Technological Advancements in Manufacturing Platforms
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Production Complexity and Cost
      • 3.2.2.2. Limited Skilled Workforce and Technical Expertise
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Nucleic Acid Therapeutics Contract Manufacturing Market: Type Estimates & Trend Analysis

  • 4.1. Nucleic Acid Therapeutics Contract Manufacturing Market, By Type: Segment Dashboard
  • 4.2. Nucleic Acid Therapeutics Contract Manufacturing Market, By Type: Movement Analysis
  • 4.3. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
  • 4.4. Gene Therapy
    • 4.4.1. Gene Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Plasmid DNA (pDNA)
      • 4.4.2.1. Plasmid DNA (pDNA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Viral Vectors
      • 4.4.3.1. Viral Vectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Non-viral Gene Delivery Systems
      • 4.4.4.1. Non-viral Gene Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. RNA-based Therapies
    • 4.5.1. RNA-based Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Messenger RNA (mRNA)
      • 4.5.2.1. Messenger RNA (mRNA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Small Interfering RNA (siRNA)
      • 4.5.3.1. Small Interfering RNA (siRNA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Antisense Oligonucleotides (ASO)
      • 4.5.4.1. Antisense Oligonucleotides (ASO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Nucleic Acid Therapeutics Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 5.1. Nucleic Acid Therapeutics Contract Manufacturing Market, By Service: Segment Dashboard
  • 5.2. Nucleic Acid Therapeutics Contract Manufacturing Market, By Service: Movement Analysis
  • 5.3. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 5.4. Process Development and Optimization
    • 5.4.1. Process Development and Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. GMP Manufacturing
    • 5.5.1. GMP Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Analytical and Quality Control Service
    • 5.6.1. Analytical and Quality Control Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Fill-Finish Contract Manufacturing
    • 5.7.1. Fill-Finish Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Regulatory Support
    • 5.8.1. Regulatory Support Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Nucleic Acid Therapeutics Contract Manufacturing Market: Application Estimates & Trend Analysis

  • 6.1. Nucleic Acid Therapeutics Contract Manufacturing Market, By Application: Segment Dashboard
  • 6.2. Nucleic Acid Therapeutics Contract Manufacturing Market, By Application: Movement Analysis
  • 6.3. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates & Forecasts, By Application, 2021 - 2033 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Rare Diseases
    • 6.5.1. Rare Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Genetic Disorders
    • 6.6.1. Genetic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Infectious Diseases
    • 6.7.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Nucleic Acid Therapeutics Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 7.1. Nucleic Acid Therapeutics Contract Manufacturing Market, By End Use: Segment Dashboard
  • 7.2. Nucleic Acid Therapeutics Contract Manufacturing Market, By End Use: Movement Analysis
  • 7.3. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 7.4. Large Biopharmaceutical Companies
    • 7.4.1. Large Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Medium Biopharmaceutical Companies
    • 7.5.1. Medium Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Small Biopharmaceutical Companies
    • 7.6.1. Small Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Nucleic Acid Therapeutics Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Key Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Lonza Group
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Thermo Fisher Scientific
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Catalent Inc.
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. WuXi AppTec
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. AGC Biologics
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Agilent Technologies
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Ajinomoto Bio-Pharma Services
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. BioSpring GmbH
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Bachem Holding AG
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. CordenPharma International GmbH
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Danaher Corporation
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Eurofins Scientific
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Avecia (Nitto Denko / Avecia)
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. BioCina Pty Ltd.
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Kaneka Corporation
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-809-4

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 4 Global Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 5 Global Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 6 Global Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 9 North America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 10 North America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 11 North America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 12 U.S. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 13 U.S. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 14 U.S. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 15 U.S. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Canada Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 17 Canada Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 Canada Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 19 Canada Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Mexico Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 21 Mexico Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 22 Mexico Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 23 Mexico Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 24 Europe Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 26 Europe Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 27 Europe Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 28 Europe Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 29 UK Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 30 UK Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 31 UK Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 32 UK Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 33 Germany Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 34 Germany Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 35 Germany Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 36 Germany Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 37 France Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 38 France Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39 France Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 40 France Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Italy Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 42 Italy Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Italy Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 44 Italy Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 45 Spain Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 46 Spain Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 47 Spain Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 48 Spain Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 49 Denmark Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 50 Denmark Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 51 Denmark Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 52 Denmark Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 53 Sweden Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 54 Sweden Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 55 Sweden Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 56 Sweden Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 57 Norway Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 58 Norway Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 59 Norway Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 60 Norway Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Japan Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 67 Japan Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 68 Japan Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 69 Japan Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 70 China Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 71 China Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 72 China Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 73 China Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 74 India Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 75 India Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 76 India Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 77 India Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 78 Australia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 79 Australia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 80 Australia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 81 Australia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 82 Thailand Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 83 Thailand Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 84 Thailand Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 85 Thailand Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 86 South Korea Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 87 South Korea Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 88 South Korea Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 89 South Korea Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 90 Latin America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 92 Latin America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 93 Latin America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 94 Latin America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Brazil Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 96 Brazil Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 97 Brazil Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 98 Brazil Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 99 Argentina Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 100 Argentina Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 101 Argentina Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 102 Argentina Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 108 South Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 109 South Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 110 South Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 111 South Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 116 UAE Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 117 UAE Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 118 UAE Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 119 UAE Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 124 Oman Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 125 Oman Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 126 Oman Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 127 Oman Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 128 Qatar Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 129 Qatar Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 130 Qatar Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 131 Qatar Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Nucleic Acid Therapeutics Contract Manufacturing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Nucleic Acid Therapeutics Contract Manufacturing Market: Type outlook and key takeaways
  • Fig. 20 Nucleic Acid Therapeutics Contract Manufacturing Market: Type movement analysis
  • Fig. 21 Gene Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Plasmid DNA (pDNA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Viral Vectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Non-viral Gene Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 RNA-based Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Messenger RNA (mRNA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Small Interfering RNA (siRNA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Antisense Oligonucleotides (ASO) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Nucleic Acid Therapeutics Contract Manufacturing Market: Service outlook and key takeaways
  • Fig. 32 Nucleic Acid Therapeutics Contract Manufacturing Market: Service movement analysis
  • Fig. 33 Process Development and Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 GMP Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Analytical and Quality Control Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Fill-Finish Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Regulatory Support Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Nucleic Acid Therapeutics Contract Manufacturing Market: Application Outlook And Key Takeaways
  • Fig. 40 Nucleic Acid Therapeutics Contract Manufacturing Market: Application Movement Analysis
  • Fig. 41 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Rare Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Genetic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Nucleic Acid Therapeutics Contract Manufacturing Market: End Use Outlook And Key Takeaways
  • Fig. 47 Nucleic Acid Therapeutics Contract Manufacturing Market: End Use Movement Analysis
  • Fig. 48 Large Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Medium Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Small Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Regional Marketplace: Key Takeaways
  • Fig. 53 North America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 U.S. Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Canada Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Mexico Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Europe Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 UK Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Germany Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 France Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Italy Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Spain Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Denmark Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Sweden Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Norway Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Asia Pacific Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Japan Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 China Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 India Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Australia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Thailand Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Korea Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Latin America Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Brazil Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Argentina Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 MEA Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 South Africa Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 UAE Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Saudi Arabia Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Kuwait Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Qatar Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 Oman Nucleic Acid Therapeutics Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Key company categorization
  • Fig. 110 Service heat map analysis
  • Fig. 111 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!